Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
brand name drug
contraceptive medication |
| gptkbp:activeIngredient |
gptkb:medroxyprogesterone_acetate
|
| gptkbp:alternativeName |
Depo-Provera 104 mg
Depo-Provera SC Depo-Provera subcutaneous |
| gptkbp:ATCCode |
gptkb:G03AC06
|
| gptkbp:contraindication |
known or suspected pregnancy
liver dysfunction undiagnosed vaginal bleeding active thrombophlebitis |
| gptkbp:form |
suspension for injection
104 mg |
| gptkbp:frequency |
every 3 months
|
| https://www.w3.org/2000/01/rdf-schema#label |
Depo-SubQ Provera 104
|
| gptkbp:indication |
contraception
endometriosis-associated pain |
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:marketedIn |
gptkb:Canada
gptkb:United_States various countries |
| gptkbp:pregnancyCategory |
X
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:regulates |
approved
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
abdominal pain
headache weight gain irregular bleeding bone mineral density loss |
| gptkbp:bfsParent |
gptkb:medroxyprogesterone_acetate
|
| gptkbp:bfsLayer |
7
|